Novo Integrated Sciences Stock Current Liabilities
NVOSDelisted Stock | USD 0.04 0.01 17.57% |
Novo Integrated Sciences fundamentals help investors to digest information that contributes to Novo Integrated's financial success or failures. It also enables traders to predict the movement of Novo OTC Stock. The fundamental analysis module provides a way to measure Novo Integrated's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novo Integrated otc stock.
Novo |
Novo Integrated Sciences OTC Stock Current Liabilities Analysis
Novo Integrated's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
In accordance with the recently published financial statements, Novo Integrated Sciences has a Current Liabilities of 0.0. This is 100.0% lower than that of the Health Care Providers & Services sector and about the same as Health Care (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Novo Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.Novo Integrated is currently under evaluation in current liabilities category among its peers.
Novo Fundamentals
Return On Equity | -1.35 | ||||
Return On Asset | -0.18 | ||||
Profit Margin | (1.80) % | ||||
Operating Margin | (0.80) % | ||||
Current Valuation | 5.8 M | ||||
Shares Outstanding | 19.05 M | ||||
Shares Owned By Insiders | 6.82 % | ||||
Shares Owned By Institutions | 5.77 % | ||||
Number Of Shares Shorted | 274.86 K | ||||
Price To Book | 0.29 X | ||||
Price To Sales | 0.21 X | ||||
Revenue | 12.57 M | ||||
Gross Profit | 3.82 M | ||||
EBITDA | (5.63 M) | ||||
Net Income | (13.27 M) | ||||
Cash And Equivalents | 12.68 M | ||||
Cash Per Share | 0.41 X | ||||
Total Debt | 4.47 M | ||||
Debt To Equity | 0.48 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 0.52 X | ||||
Cash Flow From Operations | (2.24 M) | ||||
Short Ratio | 1.13 X | ||||
Earnings Per Share | (0.41) X | ||||
Number Of Employees | 127 | ||||
Beta | -0.69 | ||||
Market Capitalization | 2.84 M | ||||
Total Asset | 35.56 M | ||||
Retained Earnings | (67.03 M) | ||||
Working Capital | (3.52 M) | ||||
Net Asset | 35.56 M |
About Novo Integrated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Integrated Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Novo OTC Stock
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets |